These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2154250)

  • 1. Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
    Capranico G; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1990 Jan; 29(2):562-9. PubMed ID: 2154250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
    Pommier Y; Capranico G; Orr A; Kohn KW
    J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.
    Pommier Y; Capranico G; Orr A; Kohn KW
    Nucleic Acids Res; 1991 Nov; 19(21):5973-80. PubMed ID: 1658748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activity.
    Andrivon W; Saucier JM; Auclair C; Monneret C; Florent JC; Guillosson JJ; Nafziger J
    Leuk Res; 1996 Feb; 20(2):119-26. PubMed ID: 8628010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
    Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
    Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
    Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
    Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase II as the primary target of anti-tumor anthracyclines.
    Zunino F; Capranico G
    Anticancer Drug Des; 1990 Nov; 5(4):307-17. PubMed ID: 1963303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I].
    Dezhenkova LG; Teviashova AN; Olsuf'eva EN; Treshchalin ID; Shtil' AA; Preobrazhenskaia MN
    Bioorg Khim; 2008; 34(3):430-2. PubMed ID: 18672696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
    Fesen M; Pommier Y
    J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
    Yang L; Rowe TC; Nelson EM; Liu LF
    Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
    Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.
    Capranico G; Kohn KW; Pommier Y
    Nucleic Acids Res; 1990 Nov; 18(22):6611-9. PubMed ID: 2174543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
    De Isabella P; Zunino F; Capranico G
    Nucleic Acids Res; 1995 Jan; 23(2):223-9. PubMed ID: 7862525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.